San Francisco-based private investment bank backs innovative stem cell processing, manufacturing, and bio-storage company with a leading position in dental stem cell storage and related services.
San Francisco, CA, USA., February 14, 2017 — US Capital Partners Inc. has been engaged by Provia Laboratories, LLC (“Provia”) as its strategic advisor for a $2 million convertible debt financing. Provia will use the new financing to expand sales and marketing activities, retire existing debt, and provide general working capital as the business continues to grow.
US Capital Partners Inc. is a private investment bank headquartered in San Francisco. Through its affiliate broker dealer, US Capital Global Securities, LLC, the firm facilitates equity private placements, makes direct debt investments, participates in debt facilities, and has a wide distribution for these services and financial products for small and medium-sized businesses.
“We are extremely pleased to be assisting Provia with its business financing needs in a strategic investment banking role, as the company moves into the next phase of its business expansion,” said Jeffrey Sweeney, Chairman and CEO at US Capital Partners. “The opportunity to participate in Provia’s $2 million convertible debt financing raise is now open to eligible investors through our digital investment platform, available at www.uscgs.com, which offers a curated selection of private placement opportunities.”
“At the core of Provia’s vision, we believe in helping individuals benefit from their own cells,” said Howard Greenman, CEO at Provia. “Store-A-Tooth offers one of the few opportunities we have as parents to collect and preserve our children’s stem cells when our children are young, and their cells are healthy. We have prepared our business to scale, and plan to work nationally with dental and oral surgery offices, expand our direct-to-consumer activities, and bring our technology to additional markets through strategic partnerships.”
About Provia Laboratories, LLC:
Provia is a revenue-generating stem cell processing, manufacturing, and bio-storage company with a leading position in dental stem cell storage and related services. Provia’s primary service, Store-A-Tooth™, provides private storage of stem cells from children’s teeth for future use in the child’s personalized regenerative medicine. Store-A-Tooth™ is a similar service to cord blood stem cell banks like ViaCord (purchased by PerkinElmer) and Cord Blood Registry (purchased by AMAG Pharma). Provia has a proprietary set of protocols for cell processing, expansion, validation, and cryopreser¬vation. Provia’s laboratory provides these services under FDA guidelines for current good manufacturing practice (cGMP) for human cell and tissue products.
About US Capital Partners Inc.
Since 1998, US Capital Partners has been providing well-structured, custom finance solutions to private and public companies in the United States and abroad. Headquartered in San Francisco, US Capital Partners, operating with its affiliate US Capital Global Securities, LLC, is a full-service private investment bank with a wide distribution for debt and equity private placements. The group makes debt investments between $500,000 and $100 million, participates in debt facilities, and offers asset management, financial advisory services for buy-side and sell-side engagements, and capital formation, including early-stage financings requiring equity or debt. For more information, visit www.uscapitalpartners.net.
To learn more about this recent engagement or about how a business can secure the investment banking services it needs, email Jeffrey Sweeney, Chairman and CEO, at firstname.lastname@example.org or call +1 (415) 889-1010.
US Capital Partners, Inc
555 Montgomery Street, Suite 1501
San Francisco, CA 94111